Product
Autologous Human Schwann Cells
1 clinical trial
1 indication
Indication
Peripheral Nerve InjuriesClinical trial
The Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury (PNI)Status: Active (not recruiting), Estimated PCD: 2025-09-01